Cytopathology Monthly QI Meeting

---

RSS

Occurs monthly on the 3rd Tuesday starting on 4/18/2023 at 8:00 AM
Tuesday, April 18, 2023, 8:00 AM - 9:00 AM, Virtual


AMA PRA Category 1 Credits™ (1.00 hours), ABPath MOC Part II (1.00 hours), Non-Physician Attendance (1.00 hours)

Cytopathology series is designed to review current practices, detect any trends that can be used for trouble-shooting, and address discrepancies. This series will keep the Cytology team up to date on changes within our practice and a forum for discussion on pressing issues.

1. Analyze relevant quality metrics within the cytopathology laboratory, update on current practices, and sharpen analytical skills regarding quality assurance within the cytopathology laboratory
2. Apply trouble shooting and problem solving skills for cytopathology laboratory management

This series is invite only. Please contact Gerald Pendleton for more information at [email protected] 

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.